The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 A resolution: implications for a new mode of inhibition
about
Mechanism-based inhibition of the melatonin rhythm enzyme: pharmacologic exploitation of active site functional plasticityFlexible ligand docking using conformational ensemblesRole of an invariant lysine residue in folate binding on Escherichia coli thymidylate synthase: Calorimetric and crystallographic analysis of the K48Q mutantDesign, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitorsDevelopment and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid (BGC 945), a novel thymidylate synthase inhibitor that targetsCrystal structure of avian aminoimidazole-4-carboxamide ribonucleotide transformylase in complex with a novel non-folate inhibitor identified by virtual ligand screening.Bacterial Thymidylate Synthase Binds Two Molecules of Substrate and Cofactor without Cooperativity.Thymidylate synthase inhibition: a structure-based rationale for drug design.Docking molecules by families to increase the diversity of hits in database screens: computational strategy and experimental evaluation.Probing the folate-binding site of human thymidylate synthase by site-directed mutagenesis. Generation of mutants that confer resistance to raltitrexed, Thymitaq, and BW1843U89.
P2860
Q24655023-67514550-14BF-4B37-BEFA-722B9BE96613Q24673137-72C87477-A6C1-4AFC-A954-52FC00E3E1F2Q27650302-50068DE2-5CFF-441E-892B-82D4869936D5Q27667755-217FE9D7-D10A-479D-B0B5-A158DE4CE887Q27678339-D9EF35AA-54BF-4690-B2E4-F4FD0876F570Q33206581-36347591-3DB1-4606-8FDE-CA311AED1449Q40375331-8456E7B1-3597-4625-A4B4-9EF7461CFFF1Q40872442-7107811A-3B2B-4820-AB9A-D4FD4335368FQ43512278-6F860EB9-1507-4D63-B6B9-4948082B115FQ54117221-9B1C77E7-08C6-4979-BD6A-8466720C51FE
P2860
The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 A resolution: implications for a new mode of inhibition
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The complex of the anti-cancer ...... s for a new mode of inhibition
@ast
The complex of the anti-cancer ...... s for a new mode of inhibition
@en
The complex of the anti-cancer ...... s for a new mode of inhibition
@nl
type
label
The complex of the anti-cancer ...... s for a new mode of inhibition
@ast
The complex of the anti-cancer ...... s for a new mode of inhibition
@en
The complex of the anti-cancer ...... s for a new mode of inhibition
@nl
prefLabel
The complex of the anti-cancer ...... s for a new mode of inhibition
@ast
The complex of the anti-cancer ...... s for a new mode of inhibition
@en
The complex of the anti-cancer ...... s for a new mode of inhibition
@nl
P1433
P1476
The complex of the anti-cancer ...... s for a new mode of inhibition
@en
P2093
R M Stroud
P356
10.1016/S0969-2126(96)00010-X
P50
P577
1996-01-01T00:00:00Z